Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Income Taxes

v2.4.0.6
Income Taxes
12 Months Ended
Mar. 31, 2012
Income Taxes [Abstract]  
Income Taxes

15.  Income Taxes

Income tax benefit (expense) includes income taxes currently payable and those deferred because of temporary differences between the financial statement and tax bases of assets and liabilities. Income tax (expense) benefit consists of the following components:

                                     
    Years Ended 31 March      
 (Millions of US dollars)   2012          2011          2010       
             

Income (loss) from operations before income taxes:

                                   

Domestic1

    $       97.1           $     66.5           $     12.8      

Foreign

    54.0           30.1           (31.5    
   

 

 

 

 

 

 

 

 

Total income (loss) before income taxes

    $ 151.1           $ 96.6           $ (18.7    
   

 

 

 

 

 

 

 

 

Income tax benefit (expense):

                                   

Current:

                                   

Domestic1

    $ (2.5         $ (15.6         $ 0.6      

Foreign

    454.3           (447.4         (137.7    
   

 

 

 

 

 

 

 

 

Current income tax benefit (expense)

    451.8           (463.0         (137.1    
   

 

 

 

 

 

 

 

 

Deferred:

                                   

Domestic1

    (4.2         (22.2         (0.9    

Foreign

    5.6           41.6           71.8      
   

 

 

 

 

 

 

 

 

Deferred income tax benefit

    1.4           19.4           70.9      
   

 

 

 

 

 

 

 

 

Total income tax benefit (expense)

    $ 453.2           $ (443.6         $ (66.2    
   

 

 

 

 

 

 

 

 

 

1 Since JHI SE became an Irish parent holding company during fiscal year 2011, domestic represents both Ireland and The Netherlands for fiscal year 2011. For fiscal year 2010, domestic represents The Netherlands.

Income tax benefit (expense) computed at the statutory rates represents taxes on income applicable to all jurisdictions in which the Company conducts business, calculated at the statutory income tax rate in each jurisdiction multiplied by the pre-tax income attributable to that jurisdiction.

 

Income tax benefit (expense) is reconciled to the tax at the statutory rates as follows:

 

                                     
    Years Ended 31 March      
 (Millions of US dollars)   2012          2011          2010       
             

Income tax (expense) benefit at statutory tax rates

      $      (28.4           $      (18.3           $    8.3      

US state income taxes, net of the federal benefit

    (0.8         (1.7         (3.7    

Asbestos – effect of foreign exchange

    (1.9         (31.7         (66.4    

Benefit from Dutch financial risk reserve regime

    -             -             3.2      

Expenses not deductible

    (0.7         (4.0         (3.7    

Non-assessable items

    0.4           -             2.0      

Income (losses) not available for carryforward

    1.1           0.7           (0.6    

Repatriation of foreign earnings

    (0.1         (32.6         -        

Change in reserves

    1.0           (0.2         (2.2    

Amortisation of intangibles

    1.7           (5.9         -        

Taxes on foreign income

    2.6           (2.0         (1.6    

State amended returns and audit

    (0.5         -             (2.2    

Tax assessment in dispute

    478.4           (349.1         -        

Other permanent items

    0.4           1.2           0.7      
   

 

 

 

 

 

 

 

 

Total income tax benefit (expense)

    $ 453.2           $ (443.6         $ (66.2    
   

 

 

 

 

 

 

 

 

Effective tax rate

    299.9%           -459.2%           354.0%      
   

 

 

 

 

 

 

 

 

Deferred tax balances consist of the following components:

 

                         
    31 March      
 (Millions of US dollars)   2012          2011       
         

Deferred tax assets:

                       

Asbestos liability

    $     444.5           $     461.9      

Other provisions and accruals

    49.0           35.7      

Net operating loss carryforwards

    11.0           32.5      

Capital loss carryforwards

    34.5           34.3      
   

 

 

 

 

 

          Total deferred tax assets

    539.0           564.4      

Valuation allowance

    (42.1         (43.1    
   

 

 

 

 

 

          Total deferred tax assets, net of valuation allowance

    496.9           521.3      
   

 

 

 

 

 

Deferred tax liabilities:

                       

Depreciable and amortisable assets

    (117.3         (114.9    

Unremitted earnings

    -             (32.6    

Other

    (8.6         (4.2    
   

 

 

 

 

 

          Total deferred tax liabilities

    (125.9         (151.7    
   

 

 

 

 

 

          Net deferred tax assets

    $ 371.0           $ 369.6      
   

 

 

 

 

 

The Company establishes a valuation allowance against a deferred tax asset if it is more likely than not that some portion or all of the deferred tax asset will not be realised. The Company has established a valuation allowance pertaining to all of its Australian and European capital loss carry-forwards. The valuation allowance decreased by US$1.0 million during fiscal year 2012 due to foreign currency movements.

At 31 March 2012, the Company had a US tax loss carry-forward of US$7.4 million that will expire in 2031 and a US tax loss of US$5.8 million in respect of which a benefit will be recorded in additional paid in capital when the loss is realised.

At 31 March 2012, the Company had US$115.1 million in Australian capital loss carry-forwards which will never expire. At 31 March 2012, the Company had a 100% valuation allowance against the Australian capital loss carry-forwards.

At 31 March 2012, the Company had European tax loss carry-forwards of approximately US$28.9 million that are available to offset future taxable income, of which US$23.3 million will never expire. Carry-forwards of US$5.6 million will expire in fiscal years 2015 through 2018. At 31 March 2012, the Company had a 100% valuation allowance against the European tax loss carry-forwards.

In determining the need for and the amount of a valuation allowance in respect of the Company’s asbestos related deferred tax asset, management reviewed the relevant empirical evidence, including the current and past core earnings of the Australian business and forecast earnings of the Australian business considering current trends. Although realisation of the deferred tax asset will occur over the life of the AFFA, which extends beyond the forecast period for the Australian business, Australia provides an unlimited carry-forward period for tax losses. Based upon managements’ review, the Company believes that it is more likely than not that the Company will realise its asbestos related deferred tax asset and that no valuation allowance is necessary as of 31 March 2012. In the future, based on review of the empirical evidence by management at that time, if management determines that realisation of its asbestos related deferred tax asset is not more likely than not, the Company may need to provide a valuation allowance to reduce the carrying value of the asbestos related deferred tax asset to its realisable value.

At 31 March 2012, the undistributed earnings of non-Irish subsidiaries approximated US$236.9 million. Except for the undistributed earnings of the Company’s US subsidiaries and of RCI, the Company intends to indefinitely reinvest its undistributed earnings of non-Irish subsidiaries and has not provided for taxes that would be payable upon remittance of those earnings. The amount of the potential deferred tax liability related to undistributed earnings is impracticable to determine at this time.

Due to the size and nature of its business, the Company is subject to ongoing reviews by taxing jurisdictions on various tax matters. The Company accrues for tax contingencies based upon its best estimate of the taxes ultimately expected to be paid, which it updates over time as more information becomes available. Such amounts are included in taxes payable or other non-current liabilities, as appropriate. If the Company ultimately determines that payment of these amounts is unnecessary, the Company reverses the liability and recognises a tax benefit during the period in which the Company determines that the liability is no longer necessary. The Company records additional tax expense in the period in which it determines that the recorded tax liability is less than the ultimate assessment it expects.

In fiscal years 2012, 2011 and 2010, the Company recorded an income tax expense of US$0.5 million, nil and US$2.2 million, respectively, as a result of the finalisation of certain tax audits (whereby certain matters were settled), the expiration of the statute of limitations related to certain tax positions.

 

The Company or its subsidiaries files income tax returns in various jurisdictions including Ireland, the United States, Australia, New Zealand, the Philippines and The Netherlands. The Company is no longer subject to US federal examinations by US Internal Revenue Service (“IRS”) for tax years prior to tax year 2009. The Company is no longer subject to examinations by The Netherlands tax authority, for tax years prior to tax year 2006. The Company is no longer subject to Australian federal examinations by the Australian Taxation Office (“ATO”) for tax years prior to tax year 2008.

Taxing authorities from various jurisdictions in which the Company operates are in the process of auditing the Company’s respective jurisdictional income tax returns for various ranges of years. The Company accrues income tax liabilities in connection with ongoing audits and reviews based on knowledge of all relevant facts and circumstances, taking into account existing tax laws, its experience with previous audits and settlements, the status of current tax examinations and how the tax authorities view certain issues.

In connection with the Company’s re-domicile from The Netherlands to Ireland, the Company became an Irish tax resident on 29 June 2010. While the Company was domiciled in The Netherlands, the Company derived significant tax benefits under the US-Netherlands tax treaty. The treaty was amended during fiscal year 2005 and became effective for the Company on 1 February 2006. The amended treaty provided, among other things, requirements that the Company must meet for the Company to qualify for treaty benefits and its effective income tax rate. During fiscal year 2006, the Company made changes to its organisational and operational structure to satisfy the requirements of the amended treaty and believes that it was in compliance and qualified for treaty benefits while the Company was domiciled in The Netherlands. However, if during a subsequent tax audit or related process, the IRS determines that these changes did not meet the requirements, the Company may not qualify for treaty benefits and its effective income tax rate could significantly increase beginning in the fiscal year that such determination is made, and it could be liable for taxes owed for calendar year 2009 and subsequent periods in which the Company was domiciled in The Netherlands.

The Company believes that it is more likely than not that it was in compliance and should qualify for treaty benefits for calendar year 2009 and subsequent periods in which the Company was domiciled in The Netherlands. Therefore, the Company believes that the requirements for recording a liability have not been met and therefore it has not recorded any liability at 31 March 2012.

 

Unrecognised Tax Benefits

A reconciliation of the beginning and ending amount of unrecognised tax benefits and interest and penalties are as follows:

 

 

                         
(US$ millions)   Unrecognised
tax benefits
  Interest and
Penalties

Balance at 31 March 2009

    $         12.3           $         (16.0    
         

Additions for tax positions of the current year

    1.2           -        

Additions (deletions) for tax positions of prior year

    4.4           (4.1    

Other reductions for the tax positions of prior periods

    (10.2         (0.6    

Foreign currency translation adjustment

    —             (6.2    
   

 

 

 

 

 

         

Balance at 31 March 2010

    $ 7.7           $ (26.9    
         

Additions for tax positions of the current year

    0.1           -        

Additions for tax positions of prior year

    153.3           195.8      

Other reductions for the tax positions of prior periods

    (0.4         (0.2    

Foreign currency translation adjustment

    24.8           27.6      
   

 

 

 

 

 

         

Balance at 31 March 2011

    $ 185.5           $ 196.3      
         

Additions for tax positions of the current year

    0.2           -        

Additions for tax positions of prior year

    -             6.1      

Settlements paid during the current period

    (184.4         (208.9    

Other reductions for the tax positions of prior periods

    (5.2         -        

Foreign currency translation adjustment

    6.5           7.4      
   

 

 

 

 

 

Balance at 31 March 2012

    $ 2.6           $ 0.9      
   

 

 

 

 

 

As of 31 March 2012, the total amount of unrecognised tax benefits and the total amount of interest and penalties accrued or prepaid by the Company related to unrecognised tax benefits that, if recognised, would affect the effective tax rate is US$2.6 million and US$0.9 million, respectively.

The Company recognises penalties and interest accrued related to unrecognised tax benefits in income tax expense. During the year ended 31 March 2012 and 2011, the total amount of interest and penalties recognised in income tax expense was US$6.1 million and US$195.6 million, respectively.

The liabilities associated with uncertain tax benefits are included in other non-current liabilities on the Company’s consolidated balance sheet.

A number of years may lapse before an uncertain tax position is audited or ultimately resolved. It is difficult to predict the ultimate outcome or the timing of resolution for uncertain tax positions. It is reasonably possible that the amount of unrecognised tax benefits could significantly increase or decrease within the next twelve months. These changes could result from the settlement of ongoing litigation, the completion of ongoing examinations, the expiration of the statute of limitations, or other circumstances. At this time, an estimate of the range of the reasonably possible change cannot be made.